BIIB Jan 2025 120.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:25PM EDT. Market open.
Loading interactive chart…
- Simply Wall St.
Shareholders 30% loss in Biogen (NASDAQ:BIIB) partly attributable to the company's decline in earnings over past year
Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that...
- Investor's Business Daily
Biogen Stock Surges After Two Notable Products Walloped Sales Expectations
Two of Biogen's newest drugs walloped first-quarter sales expectations on Wednesday, and helped Biogen stock jump.
© 2024 Yahoo. All rights reserved.